Global Gene Therapy Market Overview 2023-2032 : Forecasted Market Size and Growth Rate | Novartis AG, F.Hoffmann-La Roche Ltd, Gilead Sciences Inc., Astellas Pharma Inc., Biogen Inc.

As per The Business Research Company's Gene Therapy Opportunities And Strategies Market Report 2023, The global gene therapy market reached a value of nearly $7,370.8 million in 2022, having increased at a compound annual growth rate (CAGR) of 15.8% since 2017. The market is expected to grow from $7,370.8 million in 2022 to $24,027.1 million in 2027 at a rate of 26.7%. The market is then expected to grow at a CAGR of 13.4% from 2027 and reach $45,071.9 million in 2032.

Increasing number of cancer cases is expected to drive the growth of the gene therapy market during the forecast period. Cancer gene therapy is an emerging field using genetic material to modify cells in vitro or in vivo to help effect a cure. In gene therapy, a therapeutic human-designed new gene (transgene) was used to introduce to a subpopulation of human cells, such as human stem cells. For a cancer cell, the transgene can assist cell death or restore normal cellular functions, whereas for normal cells the transgene can protect them from drug-induced side effects and/or cytotoxicity.

View Complete Report @
https://www.thebusinessresearchcompany.com/report/gene-therapy-market

Gene therapy manufacturers are progressively investing in the launch of new manufacturing facilities and product portfolio expansion to meet the increasing demand for gene therapies and related products.
The top opportunities in the gene therapy market by vector will arise in the viral vector market, which will gain $14,868.9 million of global annual sales by 2027.

The top opportunities in the gene therapy market by application will arise in the oncology market, which will gain $7,080.0 million of global annual sales by 2027. The top opportunities in the gene therapy market by end users will arise in the biopharmaceutical companies market, which will gain $8,883.0 million of global annual sales by 2027. The top opportunities in the gene therapy market by gene therapy will arise in the somatic cell therapy market, which will gain $15,839.6 million of global annual sales by 2027. The gene therapy market size will gain the most in the USA at $4,612.0 million.

Gene Therapy Market Segmentation:
The gene therapy market is segmented by gene therapy type, by vector, by end users and by application.
By Gene Therapy Type -
a)Germline Therapy
b)Somatic Cell Therapy

By Vector -
a)Viral Vector
b)Non-Viral Vector

By End Users -
a)Biopharmaceutical Companies
b)Research Institutes
c)Other End Users

By Application -
a)Oncology
b)Orphan Disease
c)Knee Osteoarthritis
d)Neurological Disorders

Major players in the Gene Therapy market include Novartis AG, F.Hoffmann-La Roche Ltd, Gilead Sciences Inc., Astellas Pharma Inc., Biogen Inc.

The regions covered in the global Gene Therapy market are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Download FREE SAMPLE Report -
https://www.thebusinessresearchcompany.com/sample_request?id=9875&type=smp

The latest report from The Business Research Company, 'Global Gene Therapy Opportunities And Strategies Market Report - Forecast To 2032,' provides a comprehensive global perspective with data and statistics from 60+ geographies, analyzing 7000+ market segments. The regional and country breakdowns section offers insights into each geography's market analysis, size, historic and forecast growth, and key strategies for industry competitiveness.

Gene Therapy Market Report Table Of Content
1. Executive Summary
2. Table Of Contents
3. List Of Figures
4. List Of Tables
5. Report Structure
.....
19. Key Mergers And Acquisitions
20. Pipeline Analysis
21. Opportunities And Strategies
22. Gene Therapy Market, Conclusions And Recommendations
23. Appendix

PURCHASE the report @
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=9875

Get to know us better:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293

Email: info@tbrc.info
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/

This release was published on openPR.